Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medicare Drug Benefit Unlikely To Pass This Year, Lobbyist Steelman Says

Executive Summary

Congress is "very unlikely" to pass a Medicare drug benefit bill this year, Steelman Health Strategies President Deborah Steelman told a healthcare conference sponsored by the Schwab Washington Research Group May 22 in Washington, D.C.

You may also be interested in...



Thomas/Wyden Medicare Rx Plan Has Royalty On Federally Funded Research

Pharmaceutical companies would be required to pay a "return on investment fee" from profits on drugs that benefited from federal research funding under a Medicare drug benefit proposal outlined May 26 by Rep. Thomas (R-Calif.) and Sen. Wyden (D-Ore.).

Thomas/Wyden Medicare Rx Plan Has Royalty On Federally Funded Research

Pharmaceutical companies would be required to pay a "return on investment fee" from profits on drugs that benefited from federal research funding under a Medicare drug benefit proposal outlined May 26 by Rep. Thomas (R-Calif.) and Sen. Wyden (D-Ore.).

Maine Rx Pricing Law Seeks FSS-Level Prices By October 2001

The "Maine Rx" discount law seeks Federal Supply Schedule-level rebates for prescriptions filled in Maine by October 2001.

Related Content

UsernamePublicRestriction

Register

LL1135972

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel